NCT00971724View on ClinicalTrials.gov

Biomarkers of Prednisolone Treatment (P05888)

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

October 31, 2006

Study Completion Date

March 31, 2008

Conditions
Insulin ResistanceHyperglycemiaGlucose Intolerance
Interventions
DRUG

Placebo

Oral administration, once daily, for 15 days

DRUG

Prednisolone

Oral administration

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00971724 - Biomarkers of Prednisolone Treatment (P05888) | Biotech Hunter | Biotech Hunter